Fundraising Fox
Nanophage
11 employees on LinkedIn · 2 known investors
Find your way into Nanophage
Sign up to see every warm intro you have to Nanophage
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nanophage team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nanophage Technologies develops biological nanorod scaffolds for diagnostic assay applications, enabling enhanced detection and sensitivity in clinical and research settings. The company serves diagnostics manufacturers, pharmaceutical discovery organizations, and clinical laboratories.
Founders & leadership
PS
Paul SmithChief Executive OfficerPaul Smith began his career as a research chemist before transitioning to consulting and marketing leadership roles. He brings over ten years of managing director experience scaling science-based businesses across multiple regions including New Zealand, French territories, and Australia, with track records of driving revenue growth and operational efficiency.
DS
Dr Stuart BlinckoChief Technology Officer
Investors · 2
Frequently asked questions
- What does Nanophage do?
- Nanophage Technologies develops biological nanorod scaffolds for diagnostic assay applications, enabling enhanced detection and sensitivity in clinical and research settings. The company serves diagnostics manufacturers, pharmaceutical discovery organizations, and clinical laboratories.
- Who are Nanophage's investors?
- Nanophage's investors include Angel HQ, Bridgewest Ventures.
- Where is Nanophage headquartered?
- Nanophage is headquartered in Unknown, NZ.